Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Charlotte Emborg"'
Hyper- and Hypomentalizing in Patients with First-Episode Schizophrenia: fMRI and Behavioral Studies
Autor:
Birgitte Fagerlund, Chris D. Frith, Poul Videbech, Charlotte Emborg, Andreas Roepstorff, Vibeke Bliksted, Daniel Campbell-Meiklejohn, Arndis Simonsen
Publikováno v:
Bliksted, V F, Frith, C D, Videbech, P B, Fagerlund, B, Emborg, C, Simonsen, A, Roepstorff, A & Campbell-Meiklejohn, D 2019, ' Hyper-and Hypomentalizing in Patients with First-Episode Schizophrenia: fMRI and Behavioral Studies ', Schizophrenia Bulletin, vol. 45, no. 2, pp. 377-385 . https://doi.org/10.1093/schbul/sby027
Background: Historically, research investigating neural correlates of mentalizing deficits in schizophrenia has focused on patients who have been ill for several years with lengthy exposure to medication. Little is known about the neural and behaviou
Publikováno v:
Jørgensen, T R, Emborg, C, Dahlen, K, Bøgelund, M & Carlborg, A 2018, ' Patient preferences for medicine administration for acute agitation : results from an internet-based survey of patients diagnosed with bipolar disorder or schizophrenia in two Nordic countries ', Psychology, Health & Medicine, vol. 23, no. 1, pp. 30-38 . https://doi.org/10.1080/13548506.2017.1323108
The objective was to elicit patient preferences for medicine administration method in the management of acute agitation episodes among patients diagnosed with bipolar disorder or schizophrenia. The patients’ experiences of acute agitation episodes
Autor:
Jens Richardt Møllegaard Jepsen, Nikolai Albert, Merete Nordentoft, Birgitte Fagerlund, Christian Gluud, Ole Mors, Heidi Dorthe Jensen, Carsten Hjorthøj, Marianne Melau, Charlotte Emborg
Publikováno v:
The BMJ
Albert, N, Melau, M, Jensen, H, Emborg, C, Jepsen, J R M, Fagerlund, B, Gluud, C, Mors, O, Hjorthøj, C & Nordentoft, M 2017, ' Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis : randomised, superiority, parallel group trial in Denmark (OPUS II) ', B M J, vol. 356, pp. i6681 . https://doi.org/10.1136/bmj.i6681
Albert, N, Melau, M, Jensen, H, Emborg, C, Jepsen, J R M, Fagerlund, B, Gluud, C, Mors, O, Hjorthøj, C & Nordentoft, M 2017, ' Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis : randomised, superiority, parallel group trial in Denmark (OPUS II) ', BMJ (Online), vol. 356, i6681 . https://doi.org/10.1136/bmj.i6681
Albert, N, Melau, M, Jensen, H, Emborg, C, Jepsen, J R M, Fagerlund, B, Gluud, C, Mors, O, Hjorthøj, C & Nordentoft, M 2017, ' Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis : randomised, superiority, parallel group trial in Denmark (OPUS II) ', B M J, vol. 356, pp. i6681 . https://doi.org/10.1136/bmj.i6681
Albert, N, Melau, M, Jensen, H, Emborg, C, Jepsen, J R M, Fagerlund, B, Gluud, C, Mors, O, Hjorthøj, C & Nordentoft, M 2017, ' Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis : randomised, superiority, parallel group trial in Denmark (OPUS II) ', BMJ (Online), vol. 356, i6681 . https://doi.org/10.1136/bmj.i6681
OBJECTIVE: To compare the effects of five years of specialised early intervention (SEI) treatment for first episode schizophrenia spectrum disorder with the standard two years of SEI plus three years of treatment as usual.DESIGN: Randomised, superior
Publikováno v:
BMC Psychiatry
Background Agitation episodes are common among patients with schizophrenia or bipolar disorder. Oral and intramuscular administration methods are commonly used in pharmacological treatment of acute agitation. Recently, an innovative inhalation produc
Publikováno v:
Acta Psychiatrica Scandinavica. 122:356-366
Nielsen J, le Quach P, Emborg C, Foldager L, Correll CU. 10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia. Objective: The first episode of schizophrenia is a critical period for illness course and outcomes. We
Publikováno v:
Nielsen, S, Emborg, C & Mølbak, A-G 2002, ' Mortality in Concurrent Type 1 Diabetes and Anorexia Nervosa ' Diabetes Care, vol. 25, pp. 309-312 .
OBJECTIVE—Previous studies in this field report early occurrence of diabetic complications, but excess mortality, though expectable, has not been reported. We combined information from earlier studies to estimate the mortality for this group of pat
Autor:
Susanne K. Kjaer, Povl Munk-Jørgensen, Christoffer Johansen, Jørgen H. Olsen, Charlotte Emborg, Anne Tjønneland, Lene Mellemkjær, Gloria Gridley
Publikováno v:
Cancer Causes and Control. 12:173-177
Objective: Energy restriction reduces the incidence of malignant tumors in experimental animals, but evidence for a similar effect in humans is lacking. To test the hypothesis in humans, we investigated cancer incidence among patients with anorexia n
Autor:
Charlotte Emborg, Karsten Haderup, Per Damkier, Jørgen Aagaard, Jimmi Nielsen, Torben Andersen, Dorrit Thode, David Taylor, Susanne Gydesen, Jesper Dybbro, Henrik Lublin, Susanne Fabricius, Pia Glyngdal
Publikováno v:
Nielsen, J, Emborg, C, Gydesen, S, Dybbro, J, Aagaard, J, Haderup, K, Glyngdal, P, Fabricius, S, Thode, D, Lublin, H, Andersen, T, Damkier, P & Taylor, D 2012, ' Augmenting Clozapine With Sertindole : A Double-Blind, Randomized, Placebo-Controlled Study ', Journal of Clinical Psychopharmacology, vol. 32, no. 2, pp. 173-178 . https://doi.org/10.1097/JCP.0b013e318248dfb8
Nielsen, J, Emborg, C, Gydesen, S, Dybbro, J, Aagaard, J, Haderup, K, Glyngdal, P, Fabricius, S, Thode, D, Lublin, H, Damkier, P & Taylor, D 2012, ' Augmenting clozapine with sertindole : a double-blind, randomized, placebo-controlled study ', Journal of Clinical Psychopharmacology, vol. 32, no. 2, pp. 173-8 . https://doi.org/10.1097/JCP.0b013e318248dfb8
Nielsen, J, Emborg, C, Gydesen, S, Dybbro, J, Aagaard, J, Haderup, K, Glyngdal, P, Fabricius, S, Thode, D, Lublin, H, Damkier, P & Taylor, D 2012, ' Augmenting clozapine with sertindole : a double-blind, randomized, placebo-controlled study ', Journal of Clinical Psychopharmacology, vol. 32, no. 2, pp. 173-8 . https://doi.org/10.1097/JCP.0b013e318248dfb8
Clozapine augmentation with antipsychotic drugs is widely used despite sparse evidence supporting this strategy. Sertindole is a nonsedating atypical antipsychotic drug with low affinity for cholinergic receptors, which makes it potentially suitable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4b18d73d213574f79a676834de4175
https://pure.au.dk/portal/da/publications/augmenting-clozapine-with-sertindole(0ffa1f84-f345-44e7-a9a6-60967a3d2c2a).html
https://pure.au.dk/portal/da/publications/augmenting-clozapine-with-sertindole(0ffa1f84-f345-44e7-a9a6-60967a3d2c2a).html
Publikováno v:
Emborg, C, Hallerbäck, T, Jörgensen, L & Carlborg, A 2012, ' A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark ', Human Psychopharmacology: Clinical and Experimental, vol. 27, no. 5, pp. 492-8 . https://doi.org/10.1002/hup.2254
Human Psychopharmacology
Human Psychopharmacology
Objectives The atypical antipsychotic quetiapine is a first-line treatment for schizophrenia. This non-interventional study (NCT01212575) evaluated the clinical use of its two formulations, extended release (XR) and immediate release (IR), in outpati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::767e6db0ae8a8a2d4103307941b8848d
https://pure.au.dk/portal/da/publications/a-retrospective-study-of-clinical-usage-of-quetiapine-xr-and-quetiapine-ir-in-outpatients-with-schizophrenia-in-denmark(f855724c-c8c0-4c00-824d-b34f943253f1).html
https://pure.au.dk/portal/da/publications/a-retrospective-study-of-clinical-usage-of-quetiapine-xr-and-quetiapine-ir-in-outpatients-with-schizophrenia-in-denmark(f855724c-c8c0-4c00-824d-b34f943253f1).html